黑色素瘤脑转移的当前治疗方法
Agnieszka Nowacka1, Anna Fajkiel-Madajczyk2, Jakub Ohla3
1Department of Neurosurgery, Nicolas Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, ul. Curie Skłodowskiej 9, 85-094 Bydgoszcz, Poland.
Cancers
|August 26, 2023
概括
新的全身疗法,包括免疫疗法和向治疗,为患有黑色素瘤脑转移的患者提供了更好的生存期. 研究重点是免疫检查点抑制剂和BRAF/MEK抑制剂,以对抗这种晚期癌症.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 神经瘤学神经瘤学
背景情况:
- 黑色素瘤是一种高死亡率的皮肤癌,与紫外线辐射暴露密切相关.
- 大脑转移显著恶化黑色素瘤患者的预后,特别是在晚期.
- 黑色素瘤大脑转移的机制是复杂的,并未完全理解.
研究的目的:
- 总结关于治疗黑色素瘤脑转移的当前知识.
- 审查这种疾病新型全身疗法的疗效.
主要方法:
- 对黑色素瘤脑转移的全身疗法进行当前研究的综述.
- 专注于免疫治疗 (免疫检查点抑制剂:抗PD-1,抗CTLA-4) 和向治疗 (BRAF和MEK抑制剂).
主要成果:
- 瘤性BRAF突变在多达50%的转移性黑色素瘤病例中发生,有助于大脑转移的生存.
- 免疫疗法和向药物等新型疗法正在改善患者的生存率.
- 以前,生存时间仅限于6个月;新的治疗方法提供了更好的结果.
结论:
- 系统疗法,包括免疫疗法和向药物,对于改善黑色素瘤脑转移的结果至关重要.
- 对这些治疗方法的持续研究对于推进患者预后至关重要.
相关概念视频
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:27Tumor Immunotherapy
556
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
556